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Abstract Background: The mor-
tality for children with prolonged stay
in pediatric intensive care units
(PICU) is much higher than overall
mortality. The incidence of with-
drawal or limitation of therapy in this
group is unknown. Purpose: To
assess mortality and characteristics of
children admitted for C28 days to our
ICU, and to describe the extent to
which limitations of care were
involved in the terminal phase pre-
ceding death. Methods: For the
period 2003 to 2005 clinical data
were collected retrospectively for
children with prolonged stay (defined
as C28 days) in a medical/surgical
PICU of a university children’s hos-
pital. Results: In the PICU, 4.4% of
the children (116/2,607, equal gender,
mean age 29 days) had a prolonged
stay. Median (range) stay was 56 (28–
546) days. These children accounted
for 3% of total admissions and
occupied 63% of total admission
days. Mortality during admission for
this group was five times higher
(22%) than the average PICU mor-
tality rate of 4.6%. Withdrawal or
limitation of therapy preceded 70% of
deaths. Conclusions: Children with
prolonged stay in the PICU have a
significantly high risk of mortality.
Death is typically preceded by limi-
tation of care.
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Introduction
Critical appraisal of the effectiveness of different modes
of treatment and demands for more cost-efficient hospital
processes have focused attention on the duration of care
in an intensive care unit (ICU), an environment which
necessarily provides high levels of care and therefore
requires substantial operating budgets [1–3]. Median stay
for most patients is 2 days [4, 5], but a small minority
need to stay much longer and use resources in excess of
their numeric proportions [6]. Long stay in the pediatric
ICU is usually defined as stay longer than 12–13 days [1,
3, 7]. A special subgroup is formed by patients with very
prolonged stay, longer than 30 days [7, 8].
The few reports available on outcomes of long-stay
pediatric ICU patients demonstrate higher mortality and
morbidity compared with short-stay patients [3, 6, 9, 10].
Withdrawal and limitation of medical care is associated
with 14-75% of deaths in neonatal and pediatric intensive
care [11–13]. These issues have been extensively dis-
cussed in the past decade [8, 11, 12, 14–16] and have been
the subject of ongoing public discourse. The extent to
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which limitations of care actually contribute to death in
very long-stay pediatric ICU patients is not known. The
aim of the present study was to assess characteristics and
mortality of very long-stay patients in our unit and to
describe how often treatment was limited and/or
withdrawn.
Methods
Data collection and definitions
The ICU of the Erasmus MC-Sophia Children’s Hospital,
Rotterdam, is a level III interdisciplinary intensive care
unit for children in The Netherlands, providing all pedi-
atric and surgical subspecialties (except direct
cardiopulmonary bypass). All patients, including new-
borns with major congenital anomalies, admitted from 1
January 2003 until 31 December 2005 were retrospec-
tively identified using the computerized patient data
management system. Long-stay patients were defined as
those admitted for at least 28 continuous days. The reason
for this cutoff point was that 28 days is three times the
median length of stay in our unit. Whenever a long-stay
patient was readmitted, only the first admission was
included in the study. The following clinical data were
collected from hospital medical records and our patient
data management system: age, sex, presence and number
of congenital malformations, reason for admission, and
diagnosis. Both data systems are used by nursing and
medical staff.
Primary outcome was death during admission. Deaths
during operations or other procedures were classified as
intensive care deaths. Cause of death was categorized as
[13]: brain death, do-not-resuscitate, failed cardiopulmo-
nary resuscitation, withdrawal or limitation of therapy
[17–20].
Retrospectively, every patient’s death was classified
according to four categories:
1. Brain death (BD): when criteria for brain death were
fulfilled.
2. Do-not-resuscitate (DNR): when a previously ordered
DNR document was available.
3. Failed resuscitation (RES): when advanced life support
failed.
4. Withdrawal or limitation of therapy (W/LT): when, by
agreement between family and medical staff, present
level of life-sustaining treatment (LST) was limited
and/or inotropes/mechanical ventilation removed.
Main diagnoses were categorized into six groups: disor-
ders of the respiratory system, gastrointestinal disorders,
multiple congenital abnormalities, neurological disorders,
cardiac disease, and others. Data on survival, limitations
of therapy, and withdrawal of therapy were collected.
Decisions regarding do-not-resuscitate (DNR) and limi-
tation/withdrawal of life-sustaining therapy (W/LT) were
taken by a multidisciplinary team. As described earlier
[21, 22] families were involved in all cases.
Severity of illness on admission was measured by
PRISM III score according to Pollack et al. published in
1996, which was calculated from physiological data that
included the most abnormal values in the first 12 h and
second 12 h of PICU stay.
In the terminal phase, patients were not transferred to
a different ward. Instead, optimal palliative care was
offered in a separate part of the intensive care unit. When
needed or requested by the medical team and/or parents,
the institutional Ethics Review Board was consulted.
Approval from this board for the present study was
waived due to its retrospective character.
Setting
The setting for this study was a 34-bed multidisciplinary
tertiary level III pediatric ICU with extra corporeal
membrane oxygenation (ECMO) facilities, including a
6-bed step-down unit. This ICU is part of a 250-bed
pediatric university hospital with a referral population of
4,000,000 and staffed full-time by intensive care spe-
cialists with basic training in pediatrics or anesthesiology.
Data analysis
Data are presented as mean ± standard deviation (SD) or
median (interquartile range [IQR] or range) where
appropriate and were analyzed by using SPSS software
(SPSS version 12.0 for Windows, 2005, Chicago, IL).
Results
During the study period 2,607 patients were admitted on
3,700 occasions for a total of 16,013 admission days. Of
this group 4.4% (116/2,607) patients were identified as
very long-stay patients, responsible for 3.4% (126/3,700)
of total admissions and consuming 63% (10,055/16,013)
of admission days. One hundred and six long-stay patients
were admitted once, seven were admitted twice, and three
were admitted three times.
Demographic and care characteristics of long-stay
patients are summarized in Table 1. Clinical diagnoses
were: disorders of the respiratory system (29, 25%),
gastrointestinal disorders (23, 20%), multiple congenital
abnormalities (19, 16%), neurological disorders (18,
15%), cardiac disease (18, 15%), and others (9, 8%).
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Their median length of stay was 56 (IQR 37–108)
days. Distribution of length of stay is shown in Fig. 1.
Outliers were three patients admitted for more than
300 days, the longest stay being 546 days. PRISM III
scores are shown in Fig. 2. The majority of the long-stay
patients (58%) had a PRISM III score between 0 and 5.
Ninety-four patients (81%) had a maximum PRISM III
score of 10.
During the study period 4.6% (120/2,607) of the total
patient group died during admission; 21% (25/120) of
them were very long-stay patients. The mortality rate of
long-stay patients was higher compared with short-stay
patients [22% (25/116) versus 3.8% (95/2,491),
p \ 0.001]. The characteristics of long-stay survivors and
nonsurvivors are shown in Table 2. Neonates accounted
for half of the patient population in both groups. The most
common diagnoses among the long-stay nonsurvivors
were multiple congenital anomalies (7/25, 28%) and
cardiovascular disease (7/25, 28%). Multiple congenital
anomalies was the most frequent diagnosis among the
long-stay survivors as well (25/91, 27%), followed by
diseases of the respiratory system (22/91, 24%).
The specific primary diagnoses which led to long stay
are presented in Table 3. A total of 101 readmissions
were counted for 91 survivors. Comparing different
Table 1 Demographic characteristics of long-stay patients
Demographic characteristics Long-stay patients Long-stay nonsurvivors Long-stay survivors
N = 116 N = 25 N = 91
Admissions 126 25 111
Fraction of total admissions (%) 3 2.6 0.6
Males (%) 57 60 58
Age median (months) (IQR 25) 1 1 1
Mean age (months) 29 29 29
Mortality (%) 22 – –
Surgical patients (%) 37 36 34
Median ventilation (days) (IQR 25) 30 33 45
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Fig. 1 Length of intensive care unit stay in days for a total of 116
long-stay patients
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Fig. 2 PRISM III score among long-stay patients
Table 2 Characteristics of nonsurvivors and survivors
Nonsurvivors Survivors
Patient numbers 25 91
Patients no./total admissions 25 91/101
Male (%) 60 58
Median age (days) 29 34
Median length of stay (days) 67 54
Patient admission days 2,538 7,517
Neonate (%) 52 47
Ex-premature (%) 8 5
Diagnosis (%)
Resp. 2/25 (8%) 22/91 (24%)
Cardio. 7/25 (28%) 7/91 (8%)
Gastro. 4/25 (16%) 17/91 (18%)
Neuro. 4/25 (16%) 14/91 (15%)
Others. 1/25 (4%) 6/91 (7%)
MCAa 7/25 (28%) 25/91 (27%)
a Multiple congenital anomalies
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diagnosis between survivors and nonsurvivors showed no
statistical significance (p = 0.999).
Figure 3 shows a flow diagram in which end-of-life
categories are shown for nonsurvivors. No patients were
included in the category of brain death. Among 25 deaths,
6 patients had DNR status. Active withdrawal of support
occurred in 12 patients: 2 with DNR orders and 10
without. Three patients were removed from extracorpo-
real life support (ECLS): one patient after 12 days ECMO
and two cardiac patients with refractory shock. Table 4
summarizes characteristics in terms of mode-of-death
category and end-of-life treatment.
All end-of life meetings between the medical team and
family which resulted in limitations of treatment, DNR or
withdrawal were documented. The cause of death was
well documented in all the charts, including an electronic
patient data management system which has been used by
both nursing and medical staff members. Consensus
between caregivers and medical team regarding the end-
of-life meetings was reached in all cases. All parents were
physically present with their child when passing away,
except one parent couple who, with respect to their reli-
gious restrictions, unfortunately could not be present at
the time of death.
Discussion
In this study the group of very long-stay patients (LOS
C28 days) forms only a small proportion of the total
cohort (3%), but they are responsible for a considerable
part of admission days (63%). The mortality rate for this
group was five times higher than that for the total cohort.
We found that our very long-stay patients consumed a
high proportion of total admission days, which is con-
sistent with earlier studies performed in adult and
pediatric ICUs (LOS [12 days) [3, 7, 20]. The overall
mortality rate in our ICU is comparable to the mortality
rates reported by European and North American studies
[1, 4, 13]. We reported a much higher mortality rate in
very long-stay patients (defined as [28 days) compared
with short-stay patients. It is difficult to compare this
mortality with earlier reports, as these were studies of
long-stay patients (defined as 7–30 days) [3, 6, 9, 10].
However, it is still lower than the ICU mortality docu-
mented among adults following very long stay (32%) [7].
Previous analysis by Marcin et al. [1] of diverse PI-
CUs in the USA indicates that, among other factors,
PRISM III score between 10 and 33 was predictive of
long stay in their population. Given that PRISM III score
has not been evaluated amongst European long-stay
patients, we considered these scores in our study sample.
The majority (81%) of our long-stay patients did have a
PRISM III score between 0 and 10, which is at the lower
range of the score and might be explained by the unique
case mix of our ICU and the PRISM III score not being
population independent.
Table 3 Specific primary diagnosis among long-stay patients
Primary diagnosis Nonsurvivors Survivors
Dilated/restricted cardiomyopathy 2 1
Congenital heart disease 7 6
Acquired arrhythmia 0 1
Congenital airway/pulmo. disease 1 4
Acquired airway/pulmo. disease 0 5
Congenital gastrointestinal
malformations
3 12
Acquired gastrointestinal disease 0 4
Congenital hypotonia 1 5
Status epilepticus (therapy resist) 1 1
Acquired neurological disease 0 1
Central hypoventilation 0 1
Infantile encephalopathy 1 3
Psychomotor retardation eci 1 1
Metabolic disease 1 2
Trauma 0 1
Sepsis 0 1
Malignancy 0 4
Multiple congenital anomalies 7 25
Congenital diaphragmatic hernia 0 12
Hematological/vascular disease 0 1
Total 25 91
BD + DNR + RES + W/LT
N = 25
W/LT(14) + DNR(6)
N = 20
RES
N = 5
BD + DNR + W/LT
N = 20
BD 
N = 0
LST
removed ( all DNR)
N = 4
Ventilation and/or inotropes
removed
N = 13
ECLS
removed
N = 3
RES : resuscitation 
BD : brain death 
DNR : Do not resuscitate 
W/LT : Withdrawal/limitation of therapy 
LST=  life-sustaining treatment 
ECLS = Extracorporeal life support 
Fig. 3 Nonsurvivors end-of-life flow diagram in different patient
groups, in which all nonsurvivors are categorized according to
mode of death. RES: resuscitation, BD: brain death, DNR: do not
resuscitate, W/LT: withdrawal/limitation of therapy, LST: life-
sustaining treatment; ECLS: extracorporeal life support. In addition
the W/LT and DNR group (n = 20) is categorized by different ICU
dependent treatments which they had been receiving
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The few studies available of adults who required at
least 28–30 days of ICU care generally report reasonable
to relatively good chance of hospital and long-term sur-
vival, with some disability during daily activities [7, 23–
27]. Friedrich et al. [7] reported a 32% ICU mortality and
a 58% hospital survival rate among their very long-stay
patients. Most survivors were discharged to their previous
place of residence, which was considered as an important
indicator of quality of life.
A high proportion of deaths in this study were pre-
ceded by end-of-life discussions, resulting in withdrawal
or limitation of life-sustaining treatment. So far, however,
there are no guidelines or protocols to facilitate the
decision-making process when establishing appropriate
boundaries concerning the extent of medical care. Once
certainty about the diagnosis and prognosis has been
obtained, it is vital that a prominent member of the
interdisciplinary teams informs the parents and evaluates
whether the treatment given is in the child’s best interest
[12, 15, 22, 28, 29]. If disagreement occurs between the
parents and the view held by the medical team, this
conflict can be mediated according to the guidelines of the
Dutch Pediatric Society, reported in the early 1990s and
available to all its members. Fortunately disagreement did
not occur in our patient group.
Optimal palliative care was provided in a separate part
of the intensive care unit without transferring the patient
to a different ward. In the holistic approach towards our
patients we appreciate continuous care given by the same
care providers. Caring for families with a child awaiting
the end of life creates a situation where an inevitable
death demands the involved care providers to continue a
close relationship, especially when a long stay has been
involved.
The retrospective character of the study is a limitation.
It was conducted in a mixed ICU population, which limits
its generalizability and application to other centers.
Moreover, our unit’s infrastructure and the lack of sepa-
rate high-dependency units within our hospital may have
had a decisive influence on our findings. The issue of
generalizability, given the different population and insti-
tutional setting, has also been raised by Friedrich et al. in
2006 when evaluating an adult ICU population [7]. They
described the unique character of their data, which may
not be applicable to other centers with a different view on
health care organization [7]. Having an intermediate/step-
down unit and long-term ventilatory facilities apart from
the intensive care might yield other results (for example,
shorter ICU length of stay). The 28-day minimum length
of stay we defined may limit the applicability of our
findings to other patient populations with severe con-
genital malformations with shorter length of stay but also
high mortality.
Notwithstanding the limitations of this type of inves-
tigation, we believe that our data on very long-stay
patients will raise awareness of this matter and contribute
towards the improvement and establishment of appropri-
ate goals of care. Long-term survival, functional
outcomes, and quality of life are important aspects of
PICU patients that need more study. Pediatric follow-up
data in long-stay patients are limited and contradictory [3,
6].
In conclusion, the high mortality rate and frequent
application of a ‘‘withholding’’ approach shown in this
Table 4 Characteristics in mode-of-death categories
BD DNR W/LT RES
Number 0 6 14 5
Age (years) mean (SD) 2.3 (4.9) 2.5 (5.6) 2.4 (5.3)
Age (years) median (range) 0.0 (0.0–3.9) 0.0 (0.0–1.5) 0.0 (0.0–6.0)
LOS (days) mean (SD) 82 (72) 102 (134) 123 (51)
LOS (days) median (range) 48 (39–136) 62 (33–107) 131 (75–167)
Initial ICU admission diagnosis (n)
Resp 3 7 –
Cardiac – 4 –
Resp ? Cardiac – 1 –
Resp ? Surgery 2 2 –
Neurology 1 – –
End-of-life treatments and characteristics
Ventilated patients (n) 6 14 –
Ventilation days 80–100% 4 12 –
Tracheostomy 2 4 –
Noninvasive ventilation – –
Multiple congenital anomaly 4 5 –
Dialysis – – –
DNR do not resuscitate
RES (failed) resuscitation
W/LT withdrawal/limitation of therapy
BD brain death
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study emphasizes the necessity of timely care assessment,
when a patient’s stay in the pediatric ICU exceeds
28 days. A multidisciplinary team should then discuss
possibilities of cure and care based on current and pre-
dicted future suffering. We recommend the use of a
transparent individualized protocol to guide the treatment
team towards boundaries of care.
Ongoing investigation is needed to point out the dif-
ferent indications and justifications of limitations of
treatment for pediatric ICU patients with prolonged length
of stay. Early identification of patients at risk of very long
stay and recognition of their high risk of mortality and
potential consequences for future therapeutic modalities
should be incorporated into the activities of teams
working at the pediatric ICU.
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